Keros Therapeutics, Inc. (NASDAQ: KROS) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT KEROS THERAPEUTICS, INC.

Keros Therapeutics, Inc. (NASDAQ: KROS)
Listen to this Section


$10.37
-0.4050 ( -3.76% ) 65.3K

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Clinical Trial Pipeline Stages


Drug Name Stage
KER-012 (cibotercept)DetailsPulmonary hypertension, Cardiovascular disease Phase 2
KER-050 (elritercept)DetailsBlood cancer, Cystic fibrosis, Lung disease, Myelofibrosis, Cancer Phase 2
KER-050 (elritercept)DetailsBlood disorder, Cancer, Myelodysplastic syndrome Phase 2
KER-065DetailsDuchenne muscular dystrophy, Neuromuscular disease Phase 1
KER-065DetailsObesity Phase 1
KER-047 (ALK2 inhibitor)DetailsMyelodysplastic syndrome, Myelofibrosis Failed
KER-047 (ALK2 inhibitor)DetailsFibrodysplasia ossificans progressiva, Anemia Failed

Market Data


Open $10.37
Previous Close $10.77
Volume 65.3K
Market Cap $207.81M
Day Range $10.29 - $10.84
52 Week Range $9.79 - $22.55
Shares Outstanding 19.79M
Change % -3.76%
Net Change ▼ -0.4050
Insider Ownership -0.06%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology
IPO Year2020
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -607,600.00

Date Type Amount Purchased Purchaser
2024-06-05 Sale -17600.00 BIENAIME JEAN JACQUES
2024-06-03 Sale -10000.00 Kariv Tomer
2024-06-03 Sale -10000.00 Knowles Julius
2024-06-03 Sale -10000.00 GRAY MARY ANN
2024-06-03 Sale -10000.00 GORDON CARL L
2024-06-03 Sale -10000.00 Farzan Nima
2024-06-03 Sale -10000.00 Nussbaum Ran
2024-06-03 Sale -10000.00 Seth Alpna
2024-02-23 Sale -125000.00 Seehra Jasbir
2024-02-15 Sale -125000.00 Seehra Jasbir

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Jun 09, 2025
4 Insider transactions 1 Jun 06, 2025
4 Insider transactions 1 Jun 06, 2025
4 Insider transactions 1 Jun 06, 2025
4 Insider transactions 1 Jun 06, 2025
8-k 8K-related 14 Jun 06, 2025
4 Insider transactions 1 Jun 06, 2025
4 Insider transactions 1 Jun 06, 2025
4 Insider transactions 1 Jun 06, 2025
4 Insider transactions 1 Jun 06, 2025

Latest News


× Before browsing our site, please accept our cookies policy